Key comorbid conditions that are predictive of survival among hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 11, 2009, Pages 1818-1826

  Miskulin, Dana ^a   Bragg Gresham, Jennifer ^b   Gillespie, Brenda W ^c   Tentori, Francesca ^b   Pisoni, Ronald L ^b   Tighiouart, Hocine ^a   Levey, Andrew S ^a   Port, Friedrich K ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; INSULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; AMPUTATION; ANAMNESIS; ARTICLE; ASCITES; CASE MIX; CELLULITIS; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GANGRENE; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS PATIENT; HOME CARE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD; NEUROLOGIC DISEASE; OXYGEN SUPPLY; PERIPHERAL VASCULAR DISEASE; PREDICTION; PROGNOSIS; QUESTIONNAIRE; RECURRENT DISEASE; SEX DIFFERENCE; SUBSTANCE ABUSE; SURVIVAL; VARIANCE;

AGED; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; CORONARY DISEASE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREDICTIVE VALUE OF TESTS; PREVALENCE; RENAL DIALYSIS; SURVIVAL ANALYSIS;

EID: 73449113653     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00640109     Document Type: Article

References (22)

1. US Renal Data System: USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
2. Miskulin DC, Meyer KB, Athienites NV, Martin AA, Marsh JV, Fink NF, Coresh J, Powe NR, Klag M, Levey AS: Comorbidity and other factors associated with modality selection in incident dialysis patients: The CHOICE Study. Am J Kidney Dis 39: 324-336, 2002
3. Goodkin DA, Young EW, Andreucci VE, Rayner HC, Held PJ: International variation in comorbid disease among hemodialysis patients: Dialysis Outcomes and Practice Patterns Study (DOPPS) [Abstract]. J Am Soc Nephrol 10: 242A, 1999
4. Fried L, Bernardini J, Piraino B: Charlson Comorbidity Index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis 37: 337-342, 2001
5. van Manen J, Korevaar J, Dekker F, Boeschoten E, Bossuyt P, Krediet R: How to adjust for comorbidity in survival studies in ESRD patients: A comparison of different indices. Am J Kidney Dis 40: 82-89, 2002
6. Van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT, Group NE-S: Adjustment for comorbidity in studies on health status in ESRD patients: Which comorbidity index to use? J Am Soc Nephrol 14: 478-485, 2003
7. Beddhu S, Bruns FJ, Saul M, Seddon P, Zeidel ML: A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 108: 609-613, 2000
8. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA: Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis 42: 125-132, 2003
9. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, McAllister CJ, Alcorn H Jr, Kopple JD, Greenland S: Revisiting mortality predictability of serum albumin in the dialysis population: Time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 20: 1880-1888, 2005
10. Kalantar-Zadeh K, Kopple J, Block G, Humphreys M: A malnutrition- inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251-1263, 2001
11. Salahudeen A: Obesity and survival on dialysis. Am J Kidney Dis 41: 925-932, 2003
12. Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, Bedrick EJ, Meyer KB, Johnson HK, Zager PG: Medical directors of dialysis clinic I: Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol 17: 513-520, 2006
13. Young E, Goodkin D, Mapes D, Port F, Keen M, Chen K, Maroni B, Wolfe R, Held P: The Dialysis Outcomes and Practice Patterns Study: An international hemodialysis study. Kidney Int 57[Suppl 74]: S74-S81, 2000
14. End Stage Renal Disease Medical Evidence Report Medicare Entitlement and/or Patient Registration, Department of Health and Human Services, Centers for Medicare & Medicaid Services. Available at: http://www.cms.hhs.gov/ cmsforms/downloads/CMS2728.pdf. Accessed September 1, 2009.
15. Miskulin D, Athienites N, Yan G, Martin A, Ornt D, Kusek J, Meyer K, Levey A: Comorbidity assessment using the Index of Coexistent Diseases (ICED) in a multicenter clinical trial: The Hemodialysis (HEMO) Study. Kidney Int 60: 1498-1510, 2001
16. Miskulin D, Meyer K, Martin A, Fink N, Coresh J, Powe N, Klag M, Levey A: Baseline comorbidity and its change predict survival in an incident dialysis population. Am J Kidney Dis 41: 149-161, 2003
17. van Manen JG, van Dijk PC, Stel VS, Dekker FW, Cleries M, Conte F, Feest T, Kramar R, Leivestad T, Briggs JD, Stengel B, Jager KJ: Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 22: 187-195, 2007
18. Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Star R, Toto R, Eknoyan G, Hemodialysis Study Group: Association of achieved dialysis dose with mortality in the hemodialysis study: An example of "dose-targeting bias." J Am Soc Nephrol 16: 3371-3380, 2005
19. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998
20. Eknoyan G, Beck G, Cheung A, Daugirdas J, Greene T, Kusek J, Allon M, Bailey J, Delmez JA, Depner T, Dwyer J, Levey A, Levin N, Milford E, Ornt D, Rocco M, Schulman G, Schwab S, Teehan B, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
21. Medicare and Medicaid Programs: Conditions for coverage for end-stage renal disease facilities. In: Code of Federal Regulations. Title 42. Pt. 494. 80, 2008
22. Iezzoni L: Risk Adjustment for Measuring Health Outcomes, 2nd Ed., Ann Arbor: Health Administration Press, 1997